IP Library Assignment 039982/0536
Patent Assignment
Reel/Frame 039982/0536

Assignment of Assignor's Interest

Recorded: 2016-10-11 Pages: 12
Assignor
SUMMIT THERAPEUTICS PLC
Executed: 2016-06-30
Assignee
SUMMIT (OXFORD) LIMITED
85B, PARK DRIVE, ABINGDON, OXFORDSHIRE, OX14 4RY, UNITED KINGDOM
Covered Property (1)
Drug Combinations for the Treatment of Duchenne Muscular Dystrophy
Patent: 8,501,713 →
Application: 12/600,242 →
Publication: US 2011/0195932
Related Assignments (6)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 5, 2010
From: WYNNE, GRAHAM MICHAEL; WREN, STEPHEN PAUL; JOHNSON, PETER DAVID; PRICE, PAUL DAMIEN
To: SUMMIT CORPORATION PLC
Reel/Frame 024039/0042 →
Assignment of Assignor's Interest Mar 5, 2010
From: SUMMIT CORPORATION PLC
To: BIOMARIN IGA LIMITED
Reel/Frame 024039/0102 →
Assignment of Assignor's Interest Nov 30, 2010
From: BIOMARIN IGA LIMITED
To: SUMMIT CORPORATION PLC
Reel/Frame 025435/0607 →
Assignment of Assignor's Interest Jun 15, 2016
From: TINSLEY, JONATHON MARK
To: SUMMIT CORPORATION PLC
Reel/Frame 038918/0995 →
Change of Name Jan 6, 2017
From: SUMMIT CORPORATION PLC
To: SUMMIT THERAPEUTICS PLC
Reel/Frame 041365/0390 →
Assignment of Assignor's Interest Feb 7, 2018
From: SUMMIT THERAPEUTICS PLC
To: SUMMIT (OXFORD) LIMITED
Reel/Frame 044859/0983 →